Journal, April 30, 2019
EGLN Inhibitor Protects Normal Tissue and Enables RT in Mouse Model of Pancreatic Cancer
"Hypoxic cells induce a powerul regenerative response, resulting in the protection of tissue." - Cullen Taniguchi, M.D., Ph.D.
The American Association for Cancer Research publishes an article covering a powerful enzyme studied in the Taniguchi lab. EGLN is a protein that regulates cell behavior before hypoxia, enabling healthy cells to rapidly generate after ablative radiation therapy.
Article, April 4, 2019
Old Nuclear Fallout Study Provides Pancreatic Promise
When it comes to treating tumors in the pancreas, radiation therapy can be difficult to administer due to the pancreas' close proximity to the duodenum; a highly radiosensitive region of the small intestines. Here, Cullen Taniguchi, M.D., Ph.D., collaborates with Rice University chemistry professor, James Tour, Ph.D., to investigate the use of Amifostine, a chemical compound with the potential to shield the small intesines of patients undergoing radiation therapy.
Podcast, Feb. 4, 2019
"Can you get cancer from what you eat?"
On this episode of the Komando Show, Kim Komando meets with Cullen Taniguchi, M.D., Ph.D., to discuss the connection between gut health and cancer.
Podcast, Feb. 17, 2019
"Kim's favorite cancer doc explains radiation technology in a way you'll actually understand."
Radio show host, Kim Komando, meets with Cullen Taniguchi, M.D., Ph.D., on her widely-acclaimed podcast to talk about developments in radiation technology that have the potential to improve outcomes for cancer patients.
WEBINAR, MARCH 2018
Oxygen Sensing in Cancer and Metabolism
In this webinar, Cullen Taniguchi, M.D., Ph.D., joins other experts to discuss discuss our current understanding of hypoxia-induced changes in cancer metabolism from basic research and clinical perspectives.
YOUNG SCHOLAR AWARD, 2017
Kimmel Scholars Program
The Sidney Kimmel Foundation funds the brightest young cancer researchers at the outset of their careers, including Cullen Taniguchi, M.D., Ph.D.
YOUNG SCHOLAR AWARD, 2017
V Foundation Grant
"Don't give up... Don't ever give up!" These words by legendary basketball coach Jim Valvano serve as the guidepost for the V Foundation for Cancer Research. The V Scholar Grant is awarded to young tenure-track faculty, such as Cullen Taniguchi M.D., Ph.D., for focusing on translational cancer research projects.
Cullen Taniguchi, M.D., Ph.D.
What if we could flip everything around and start by deciding that we want to protect the patient first and keep them whole?Read about Taniguchi's big ideas
Cancer, meet your match: Andrew Sabin Family Fellows announced
Eight of The University of Texas MD Anderson Cancer Center's top young researchers were named Andrew Sabin Family Fellows at an event April 21, 2016 honoring their benefactor, Andrew Sabin, and representatives of the Andrew Sabin Family Foundation. Among the awardees, Cullen Taniguchi, M.D., Ph.D., received $100,000 over two years to pursue creative, independent thinking and high-risk, high-impact research.